for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pfizer's Ibrance fails breast cancer trial

Oct 9 (Reuters) - Pfizer Inc said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in women with a type of breast cancer. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up